NIH Invests $161M in 14 New Pharmacogenomics Research Network Projects

With this new funding, the NIH hopes to continue PGx research in existing focus areas of cancer, heart disease, asthma, and nicotine addiction, and also to expand into new areas, including rheumatoid arthritis and bipolar disorder.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories